Alphabet spinoff Isomorphic Labs reportedly raising funding at up to $50B valuation

# Alphabet's Drug-Discovery AI Company Could Be Worth $50 Billion Google's parent company Alphabet is spinning off a division called Isomorphic Labs that uses AI to discover new medicines, and it's now raising money at a potential valuation of $40-50 billion. To put that in perspective, that's roughly the market value of major pharmaceutical companies, even though Isomorphic is still in its early stages of developing actual drugs. The massive valuation reflects investor confidence that AI could fundamentally transform how new medications are created.